首页> 外国专利> BENZOTIAZOLTSIKLOBUTILAMINA derivatives as ligands of histamine H3 receptors and pharmaceutical compositions thereof, process for the selective modulation effects of histamine H3 receptor and methods for treating conditions or disorders modulated by histamine H3 receptor

BENZOTIAZOLTSIKLOBUTILAMINA derivatives as ligands of histamine H3 receptors and pharmaceutical compositions thereof, process for the selective modulation effects of histamine H3 receptor and methods for treating conditions or disorders modulated by histamine H3 receptor

机译:作为组胺H3受体的配体的苯并二氮杂SIKLOBUTILAMINA衍生物及其药物组合物,组胺H3受体的选择性调节作用的方法以及由组胺H3受体调节的疾病或病症的治疗方法

摘要

1. Derivatives of benzothiazole cyclobutylamine, covered by the General structural formula (I):! ! where m is 0 or 1; ! one of R1 and R2 is selected from the group consisting of hydrogen, acyl, acyloxy group, alkenyl, alkoxy, alkoxyalkoxy group, alkoxyalkyl, alkoxycarbonyl, alkoxyimino group, alkoxy sulfonyl, alkyl, alkylcarbonyl, alkylsulfonyl, cycloalkyl, amido -, haloalkoxy, haloalkyl, halogen, hydroxy group, hydroxyalkyl, mercapto, nitro, alkylthio group, -NRARB, (NRARB) carbonyl, -SO2N (R14a) (R14b), N (R14a) SO2 (R14b), a group of the formula - L2-R6 and a group of the formula-L3a-R6a-L3b-R6b; ! the other of R1 and R2 is selected from the group consisting of hydrogen, cyano, halogen, alkyl, cycloalkyl, fluoroalkyl, alkoxy, alkoxyalkyl, fluoroalkoxy, alkylthio, —SO2N (R14a) (R14b) and —N (R14a) SO2 (R14b); ! each of R3a and R3b is independently selected from the group consisting of hydrogen, cyano, halogen, alkyl, cycloalkyl, fluoroalkyl, alkoxy, alkoxyalkyl, fluoroalkoxy, alkylthio, —SO2N (R14a) (R14b) and —N (R14a) SO2 (R14b); ! each of R4 and R5 is independently selected from the group consisting of alkyl, fluoroalkyl, hydroxyalkyl, alkoxyalkyl and cycloalkyl, or R4 and R5 taken together with the nitrogen atom to which each is attached form a non-aromatic ring; ! R6 represents aryl, heterocycle or heterocycloalkyl; ! R6a represents an aryl or heterocycle; ! R6b represents an aryl or heterocycle; ! L is a bond or alkylene; ! L2 is a bond, -O-, alkylene, -C (= O) -, -S-, -SO2N (R14a) -, -N (R14a) SO2--, -C (O) N (R14a) -, -N (R14a) C (O) - and -N (R15) -; ! each of L3a and L3b is independently selected from the group consisting of, -O-, alkylene, -C (= O) -, -S-, -SO2N (R14a) -, -N (R14a) SO2--, -C (O) N (R14a) -, -N (R14a) C (O) - and -N
机译:1.通式(I)涵盖的苯并噻唑环丁胺的衍生物: !其中m为0或1; ! R1和R2之一选自氢,酰基,酰氧基,烯基,烷氧基,烷氧基烷氧基,烷氧基烷基,烷氧基羰基,烷氧基亚氨基,烷氧基磺酰基,烷基,烷基羰基,烷基磺酰基,环烷基,酰胺基-,卤代烷氧基,卤代烷基,卤素,羟基,羟烷基,巯基,硝基,烷硫基,-NRARB,(NRARB)羰基,-SO2N(R14a)(R14b),N(R14a)SO2(R14b),式-L2-R6的基团式-L3a-R6a-L3b-R6b的基团; ! R1和R2中的另一个选自氢,氰基,卤素,烷基,环烷基,氟代烷基,烷氧基,烷氧基烷基,氟代烷氧基,烷硫基,-SO2N(R14a)(R14b)和-N(R14a)SO2(R14b) ); ! R3a和R3b各自独立地选自氢,氰基,卤素,烷基,环烷基,氟代烷基,烷氧基,烷氧基烷基,氟代烷氧基,烷硫基,-SO2N(R14a)(R14b)和-N(R14a)SO2(R14b ); ! R4和R5各自独立地选自烷基,氟烷基,羟烷基,烷氧基烷基和环烷基,或R4和R5与各自连接的氮原子一起形成非芳族环; ! R6代表芳基,杂环或杂环烷基; ! R6a代表芳基或杂环; ! R6b代表芳基或杂环; ! L为键或亚烷基; ! L 2是一个键,-O-,亚烷基,-C(= O)-,-S-,-SO2N(R14a)-,-N(R14a)SO2--,-C(O)N(R14a)-, -N(R14a)C(O)-和-N(R15)-; ! L 3a和L 3b各自独立地选自-O-,亚烷基,-C(= O)-,-S-,-SO 2 N(R 14a)-,-N(R 14a)SO 2-,-C (O)N(R14a)-,-N(R14a)C(O)-和-N

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号